Rafferty Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.77M | Buy |
34,665
+10,504
| +43% | +$1.44M | 0.02% | 412 |
|
|
2025
Q1 | $4.36M | Sell |
24,161
-3,040
| -11% | -$548K | 0.02% | 400 |
|
|
2024
Q4 | $4.26M | Sell |
27,201
-18,639
| -41% | -$2.92M | 0.02% | 447 |
|
|
2024
Q3 | $8.34M | Buy |
45,840
+4,040
| +10% | +$735K | 0.03% | 312 |
|
|
2024
Q2 | $7.68M | Sell |
41,800
-11,567
| -22% | -$2.12M | 0.03% | 324 |
|
|
2024
Q1 | $9.5M | Sell |
53,367
-30,654
| -36% | -$5.45M | 0.04% | 280 |
|
|
2023
Q4 | $10.4M | Buy |
84,021
+12,215
| +17% | +$1.52M | 0.04% | 265 |
|
|
2023
Q3 | $8.33M | Buy |
71,806
+18,623
| +35% | +$2.16M | 0.05% | 275 |
|
|
2023
Q2 | $6.24M | Sell |
53,183
-8,341
| -14% | -$979K | 0.04% | 364 |
|
|
2023
Q1 | $4.93M | Sell |
61,524
-101
| -0.2% | -$8.09K | 0.03% | 388 |
|
|
2022
Q4 | $4.88M | Buy |
61,625
+9,369
| +18% | +$742K | 0.04% | 380 |
|
|
2022
Q3 | $3.64M | Buy |
52,256
+19,064
| +57% | +$1.33M | 0.04% | 385 |
|
|
2022
Q2 | $2.18M | Sell |
33,192
-26,820
| -45% | -$1.76M | 0.02% | 444 |
|
|
2022
Q1 | $3.99M | Buy |
60,012
+27,519
| +85% | +$1.83M | 0.02% | 432 |
|
|
2021
Q4 | $2.27M | Buy |
32,493
+9,239
| +40% | +$646K | 0.01% | 611 |
|
|
2021
Q3 | $1.21M | Buy |
23,254
+892
| +4% | +$46.6K | 0.01% | 763 |
|
|
2021
Q2 | $1.52M | Sell |
22,362
-3,596
| -14% | -$245K | 0.01% | 757 |
|
|
2021
Q1 | $2M | Buy |
25,958
+21,665
| +505% | +$1.67M | 0.01% | 628 |
|
|
2020
Q4 | $258K | Sell |
4,293
-8,732
| -67% | -$525K | ﹤0.01% | 887 |
|
|
2020
Q3 | $561K | Buy |
13,025
+5,300
| +69% | +$228K | 0.01% | 672 |
|
|
2020
Q2 | $320K | Buy |
+7,725
| New | +$320K | ﹤0.01% | 814 |
|
|
2020
Q1 | – | Sell |
-12,522
| Closed | -$693K | – | 715 |
|
|
2019
Q4 | $693K | Sell |
12,522
-14,110
| -53% | -$781K | 0.01% | 629 |
|
|
2019
Q3 | $925K | Buy |
+26,632
| New | +$925K | 0.01% | 558 |
|